To explore the pathogenic role of neutrophil extracellular traps (NETs) in COVID-19 by testing a strategy to dismantle NETs using a novel therapeutic to ameliorate acute lung injury.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Mark R LooneyResearch Location
United States of AmericaLead Research Institution
University of California-San FranciscoResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
To explore the pathogenic role of neutrophil extracellular traps (NETs) in COVID-19 by testing a strategy to dismantle NETs using a novel therapeutic to ameliorate acute lung injury.